scarletred
Home
Company
Products
Scarletred
®Vision
Scarletred
®Telemedicine
Services
Applications
CAREER
News
Contact
Menu
01
Home
02
Company
03
Products
04
Services
05
Applications
06
News
07
Contact
Get in touch
Austria
SCARLETRED Holding GmbH
MQM 3.4, Maria Jacobi Gasse 1,
8th floor, 1030 Vienna, Austria
USA
SCARLETRED Inc.
1 Broadway, 14th floor,
Cambridge, MA 02142, USA
office@scarletred.com
Privacy Policy
Social
Linkedin
Linkedin
Linkedin
Twitter
Instagram
Instagram
Facebook
Facebook
info
Press
Career
FAQ
Regulatory
Imprint
Artifical intelligence
Keywords:
#
ESDR
#
AroraAI
#
Facial imagery
#
EADV
#
Forbes
#
DDDS Berlin
#
AAD 2025
News
•
Sep 5, 2025
SCARLETRED at ESDR 2025: Revolutionizing Injection Site Reaction Monitoring with validated AI
Proud to unveil our latest AI-driven innovation for injection site reaction monitoring at ESDR 2025, advancing dermatology research, care, and patient outcomes.
News
•
Sep 4, 2025
Scarletred in Forbes: From Vienna to the World - Revolutionizing Dermatology with AI
We are proud to share that Scarletred has been featured in the latest Forbes. This spotlight highlights the global impact of our groundbreaking innovations developed in the heart of Vienna, transforming dermatology worldwide.
News
•
Sep 2, 2025
SCARLETRED to Unveil Breakthrough AI Skin Research at EADV Congress 2025 in Paris
SCARLETRED joins EADV Congress 2025 in Paris to showcase AI-driven skin assessment. Discover our studies on rosacea profiling and AI-based skin type classification, highlighting how technology is transforming dermatology.
News
•
Nov 29, 2024
Scarletred Publishes Landmark Study on AI-Driven Onychomycosis Detection
Discover our latest publication showcasing the use of AI-powered Scarletred®Vision for the advanced detection and assessment of onychomycosis, a widespread fungal nail infection affecting millions worldwide.
News
•
Oct 30, 2023
SCARLETRED partnering with the 5th Inflammatory Skin Disease Summit in Vienna, Austria
We are happy to announce our attendance at the 5th Inflammatory Skin Disease Summit: The Translational Revolution to present about smart imaging and deep learning for objective psoriasis lesion scoring.
News
•
Feb 28, 2022
SCARLETRED Discovery Program (DP): SaaS as our novel flagship service for industry clinical trials
The DP aims to collaborate with pharmaceutical and biotechnology companies by providing access to our customizable software Scarletred®Vision for exploratory or early-stage clinical studies at a more attractive price point.
News
•
Nov 17, 2021
SCARLETRED’s eHealth milestones featured in Austrian Newspaper “Der Standard”
The popular newspaper Der Standard features the recent milestones of SCARLETRED in the field of teledermatology. With these, SCARLETRED sets the benchmark for AI-Assisted Screening in telemedicine and radiation oncology.
News
•
Nov 15, 2021
Dermatology & disease management: An interview with an expert about the applications of SCARLETRED
In an interview, specialist Dr. Zikeli discusses the clinical characteristics of atopic dermatitis and why documentation using Scarletred®Vision is an optimal support for diagnosis and progress monitoring.
News
•
Oct 19, 2021
SCARLETRED at the 5th Annual Dermatology Drug Development Summit
The 5th Annual Dermatology Drug Development Summit focusing on development and innovation of therapies and research targeting inflammatory skin diseases, returns to Boston for 2021.
News
•
Oct 15, 2021
Meet SCARLETRED at the 4th Inflammatory Skin Disease Summit
The Inflammatory Skin Disease Summit is a jointly organized event by the Icahn School of Medicine at Mount Sinai and the Austrian Academy of Sciences.
News
•
Nov 20, 2018
The Austrian founder who financed his startup with Tesla shares
Harald Schnidar sits across from me at lunch and doesn't even get to eat. He has too much to talk about his health startup Scarletred, which is currently in an exciting phase of its development.
Article
•
Oct 31, 2024
Scarletred Introduces Home-Based Digital Market Research for Biopharmaceutical and Cosmetic Market Research
Scarletred’s new digital market research solution offers biopharmaceutical and cosmetic companies high-quality, standardized data via Scarletred®Vision, enabling research from home with an easy-to-use kit and mobile app.
Publication
•
November 29, 2024
AI powered Detection and Assessment of Onychomycosis: A Spotlight on Yellow and Deep Learning
Read more